A Robust Deep Learning Method with Uncertainty Estimation for the Pathological Classification of Renal Cell Carcinoma Based on CT Images

被引:1
作者
Yao, Ni [1 ]
Hu, Hang [1 ]
Chen, Kaicong [2 ]
Huang, Huan [1 ]
Zhao, Chen [3 ,7 ]
Guo, Yuan [6 ]
Li, Boya [2 ]
Nan, Jiaofen [1 ]
Li, Yanting [1 ]
Han, Chuang [1 ]
Zhu, Fubao [1 ]
Zhou, Weihua [3 ,4 ,5 ]
Tian, Li [2 ]
机构
[1] Zhengzhou Univ Light Ind, Sch Comp Sci & Technol, Zhengzhou 450002, Henan, Peoples R China
[2] Sun Yat Sen Univ Canc Ctr, Guangdong Prov Clin Res Ctr Canc, Collaborat Innovat Ctr Canc Med, Dept Med Imaging,State Key Lab Oncol South China, Guangzhou 510060, Guangdong, Peoples R China
[3] Michigan Technol Univ, Dept Appl Comp, Houghton, MI 49931 USA
[4] Michigan Technol Univ, Inst Comp & Cybersystems, Ctr Biocomp & Digital Hlth, Houghton, MI 49931 USA
[5] Michigan Technol Univ, Hlth Res Inst, Houghton, MI 49931 USA
[6] First Peoples Hosp Guangzhou, Dept Radiol, Guangzhou 510180, Guangdong, Peoples R China
[7] Kennesaw State Univ, Dept Comp Sci, Marietta, GA USA
来源
JOURNAL OF IMAGING INFORMATICS IN MEDICINE | 2024年
基金
中国国家自然科学基金;
关键词
Deep learning; Renal cell carcinoma; Pathological classification; Computed tomography; LESIONS;
D O I
10.1007/s10278-024-01276-7
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
This study developed and validated a deep learning-based diagnostic model with uncertainty estimation to aid radiologists in the preoperative differentiation of pathological subtypes of renal cell carcinoma (RCC) based on computed tomography (CT) images. Data from 668 consecutive patients with pathologically confirmed RCC were retrospectively collected from Center 1, and the model was trained using fivefold cross-validation to classify RCC subtypes into clear cell RCC (ccRCC), papillary RCC (pRCC), and chromophobe RCC (chRCC). An external validation with 78 patients from Center 2 was conducted to evaluate the performance of the model. In the fivefold cross-validation, the area under the receiver operating characteristic curve (AUC) for the classification of ccRCC, pRCC, and chRCC was 0.868 (95% CI, 0.826-0.923), 0.846 (95% CI, 0.812-0.886), and 0.839 (95% CI, 0.802-0.88), respectively. In the external validation set, the AUCs were 0.856 (95% CI, 0.838-0.882), 0.787 (95% CI, 0.757-0.818), and 0.793 (95% CI, 0.758-0.831) for ccRCC, pRCC, and chRCC, respectively. The model demonstrated robust performance in predicting the pathological subtypes of RCC, while the incorporated uncertainty emphasized the importance of understanding model confidence. The proposed approach, integrated with uncertainty estimation, offers clinicians a dual advantage: accurate RCC subtype predictions complemented by diagnostic confidence metrics, thereby promoting informed decision-making for patients with RCC.
引用
收藏
页码:1323 / 1333
页数:11
相关论文
共 38 条
  • [1] An active learning method for diabetic retinopathy classification with uncertainty quantification
    Ahsan, Muhammad Ahtazaz
    Qayyum, Adnan
    Razi, Adeel
    Qadir, Junaid
    [J]. MEDICAL & BIOLOGICAL ENGINEERING & COMPUTING, 2022, 60 (10) : 2797 - 2811
  • [2] [Anonymous], KiTS19 Challenge
  • [3] Systemic therapy in the management of localized and locally advanced renal cell carcinoma: Current state and future perspectives
    Berquist, Sean W.
    Yim, Kendrick
    Ryan, Stephen T.
    Patel, Sunil H.
    Eldefrawy, Ahmed
    Cotta, Brittney H.
    Bradshaw, Aaron W.
    Meagher, Margaret F.
    Bindayi, Ahmet
    McKay, Rana R.
    Autorino, Riccardo
    Staehler, Michael
    Derweesh, Ithaar H.
    [J]. INTERNATIONAL JOURNAL OF UROLOGY, 2019, 26 (05) : 532 - 542
  • [4] A deep learning model based on whole slide images to predict disease-free survival in cutaneous melanoma patients
    Comes, Maria Colomba
    Fucci, Livia
    Mele, Fabio
    Bove, Samantha
    Cristofaro, Cristian
    De Risi, Ivana
    Fanizzi, Annarita
    Milella, Martina
    Strippoli, Sabino
    Zito, Alfredo
    Guida, Michele
    Massafra, Raffaella
    [J]. SCIENTIFIC REPORTS, 2022, 12 (01)
  • [5] Current Status of Immunotherapy for Localized and Locally Advanced Renal Cell Carcinoma
    Ghali, Fady
    Patel, Sunil H.
    Derweesh, Ithaar H.
    [J]. JOURNAL OF ONCOLOGY, 2019, 2019
  • [6] Clinical development of mTor inhibitors for renal cancer
    Ghidini, Michele
    Petrelli, Fausto
    Ghidini, Antonio
    Tomasello, Gianluca
    Hahne, Jens Claus
    Passalacqua, Rodolfo
    Barni, Sandro
    [J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2017, 26 (11) : 1229 - 1237
  • [7] The Classification of Renal Cancer in 3-Phase CT Images Using a Deep Learning Method
    Han, Seokmin
    Hwang, Sung Il
    Lee, Hak Jong
    [J]. JOURNAL OF DIGITAL IMAGING, 2019, 32 (04) : 638 - 643
  • [8] Learnable image histograms-based deep radiomics for renal cell carcinoma grading and staging
    Hussain, Mohammad Arafat
    Hamarneh, Ghassan
    Garbi, Rafeef
    [J]. COMPUTERIZED MEDICAL IMAGING AND GRAPHICS, 2021, 90
  • [9] Jocher Glenn, 2022, Zenodo
  • [10] Computer-aided diagnosis of renal lesions in CT images: A comprehensive survey and future prospects
    Kaur, Ravinder
    Juneja, Mamta
    Mandal, A. K.
    [J]. COMPUTERS & ELECTRICAL ENGINEERING, 2019, 77 : 423 - 434